MicroRNA-29a promotes apoptosis of monocytes by targeting STAT3 during sepsis

X Song1, C T Wang1, X H Geng2

  • 1Department of ICU, Shengli Hospital of Shandong University, Shandong, China.

Insights

MicroRNAs (miRNAs) like miR-29a play a key role in sepsis. This study shows miR-29a targets STAT3, inhibiting inflammation in monocytes during sepsis.

Area of Science:

  • Molecular Biology
  • Immunology
  • Critical Care Medicine

Background:

  • Sepsis is a life-threatening condition causing organ failure due to dysregulated inflammation.
  • MicroRNAs (miRNAs) are increasingly recognized for their role in sepsis pathogenesis.
  • Interleukin-10 (IL-10) activates the JAK2-STAT3 pathway, offering cellular protection during sepsis.

Purpose of the Study:

  • To investigate the role of miR-29a in targeting STAT3 during sepsis.
  • To elucidate the mechanism by which miR-29a influences IL-10-induced responses in monocytes.

Main Methods:

  • Western blotting was used to assess STAT3 activation in monocytes treated with IL-10.
  • Experimental verification confirmed STAT3 as a direct target gene of miR-29a.
  • The impact of miR-29a on IL-10-induced cytokine release was analyzed.

Main Results:

  • Interleukin-10 (IL-10) treatment activated STAT3 in human monocytes.
  • STAT3 was identified as a novel target gene of miR-29a.
  • miR-29a was shown to inhibit IL-10-induced cytokine release by targeting the JAK-STAT3 pathway in monocytes.

Conclusions:

  • This study establishes miR-29a as an inhibitor of STAT3 in human monocytes during sepsis.
  • miR-29a plays a regulatory role in the inflammatory response to sepsis via the JAK-STAT3 pathway.